X]VeiZg&+/ MEMBRANE, ORGANELLE AND CYTOSKELETAL DISORDERS
),) W^dad\nd[Y^hZVhZ
Hancock, MR (2002) Mitochondrial dysfunction and the role of the non-
specialist laboratory. Ann. Clin. Biochem.39: 456–463.Hyde, SC, Gill, DR, Higgins, CF and Trezise, EO (1993) Correction of the ion
transport defect in cystic fibrosis transgenic mice by gene therapy. Nature362:
250–255.McGuinness, MC, Wei, HM and Smith, KD (2000) Therapeutic developments in
peroxisome biogenesis disorders. Expert Opin.Investig. Drugs9: 1985–1992.Ratjen, F and Doring, G (2003) Cystic fibrosis. Lancet361: 681–689.Schwarz, MJ (1998) DNA diagnosis of cystic fibrosis. Ann. Clin. Biochem.35:
584–610.Towbin, JA (1998) The role of cytoskeletal proteins in cardiomyopathies. Curr.
Opin. Cell Biol.10: 131–139.Wanders, RJA (2004) Metabolic and molecular basis of peroxisomal disorders:
a review. Am. J. Med. Genet.126A: 355–375.Wenger, DA, Coppola, S and Liu, SL (2002) Lysosomal storage disorders:
diagnostic dilemmas and prospects for therapy. Gen. Med.4: 412–419.Yashiroda, Y and Yoshida, M (2003) Nucleo-cytoplasmic transport of proteins
as a target for therapeutic drugs. Curr. Med. Chem.10: 741–748.Yew, NS and Cheng, SH (2001) Gene therapy for lysosomal storage disorders.
Curr. Opin. Mol. Ther.3: 399–406.Useful web sites:
The Online Mendelian Inheritance in Man (OMIM™) website. Address:
http://www.ncbi.nlm.nih.gov/omim/http://www.genetsickkids.on.ca/cftr/X]VeiZg&+/ MEMBRANE, ORGANELLE AND CYTOSKELETAL DISORDERS
W^dad\nd[Y^hZVhZ